Key result
Uncomplicated Type 1 diabetes mellitus was associated with impaired flow-mediated dilatation compared to controls.
Why the study?
Are flow-mediated dilatation and microvascular reactivity impaired in patients with uncomplicated Type 1 diabetes mellitus compared to controls?
Observational (n=72)
Are flow-mediated dilatation and microvascular reactivity impaired in patients with uncomplicated Type 1 diabetes mellitus compared to controls?
Answers are grounded in this paper and cite their sources.
Impaired flow-mediated dilatation in Type 1 diabetes is multifactorial, driven by reduced diastolic shear stress and microcirculatory dysfunction rather than solely diminished nitric oxide bioavailability.
Impaired FMD (flow-mediated dilatation) has traditionally been recognized as an indirect marker of NO bioactivity, occurring in disease states such as DM (diabetes mellitus). Endothelium-dependent FMD is a homoeostatic response to short-term increases in local shear stress. Microvascular dysfunction in DM influences blood flow velocity patterns. We explored the determinants of the FMD response in relation to evoked DSS (diastolic shear stress) and forearm microcirculation haemodynamics by quantifying changes in Doppler flow velocity waveforms between groups. Forty patients with uncomplicated Type 1 DM and 32 controls underwent B-mode and Doppler ultrasound scanning to interrogate the brachial artery. Postischaemic Doppler velocity spectral envelopes were recorded and a wavelet-based time-frequency spectral analysis method was employed to track change in distal microcirculatory haemodynamics. No difference in baseline brachial artery diameter was evident between the groups (4.15 compared with 3.94 mm, P=0.23). FMD was significantly impaired in patients with Type 1 DM (3.95 compared with 7.75%, P<0.001). Endothelium-independent dilatation in response to GTN (glyceryl trinitrate) was also significantly impaired (12.07 compared with 18.77%, P<0.001). DSS (dyn/cm2) was significantly reduced in the patient group (mean 20.19 compared with 29.5, P=0.001). Wavelet interrogation of postischaemic flow velocity waveforms identified significant differences between groups. In conclusion, DSS, microcirculatory function and endothelium-independent vasodilatation in response to GTN are important determinants that impact on the magnitude of FMD response and are impaired in patients with Type 1 DM. Impaired FMD response is multifactorial in origin and cannot be attributed solely to a diminished NO bioavailability.
No takes yet. Share an insight, caveat, or question.
Lockhart et al. (2011) conducted an observational in Uncomplicated Type 1 diabetes mellitus (n=72). Type 1 diabetes mellitus vs. Controls was evaluated on Flow-mediated dilatation (FMD) (p=<0.001). Uncomplicated Type 1 diabetes mellitus was associated with impaired flow-mediated dilatation compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: